
Sign up to save your podcasts
Or


This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
By Michael Putman4.9
113113 ratings
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.

323 Listeners

499 Listeners

876 Listeners

131 Listeners

1,146 Listeners

121 Listeners

192 Listeners

172 Listeners

67 Listeners

247 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners